Mike Fairbourn is Vice President & General Manager of UK & Ireland for Becton Dickinson (BD), a leading global medical technology company and he is responsible for leading the UKI organisation for all BD businesses. He has been a member of the ABHI Board since 2016.
Previously Mike was VP for UK & Ireland for CareFusion, prior to the acquisition by BD in March 2015.
Mike joined CareFusion through the acquisition of Enturia in 2008, makers of the ChloraPrep skin preparation brand where he was General Manager, Europe. He launched the company in the UK and built a strong platform for expansion of the business into other European markets, prior to the acquisition. He was then appointed to lead the infection prevention business in international markets following the spin-off of CareFusion from Cardinal Health, before being appointed to lead the UK & Ireland organisation for BD.
He has over 25 years strategic and operational experience in the healthcare industry in a wide variety of therapeutic areas, including anti-infectives and has held senior sales and marketing positions in GSK, Abbott and Chiron.
Mike holds a bachelor of science degree in physiology and biochemistry from the University of Reading.